347 related articles for article (PubMed ID: 27932479)
1. Progress in Understanding the Genetics of Calcium-Containing Nephrolithiasis.
Sayer JA
J Am Soc Nephrol; 2017 Mar; 28(3):748-759. PubMed ID: 27932479
[TBL] [Abstract][Full Text] [Related]
2. Genetics of kidney stone disease.
Howles SA; Thakker RV
Nat Rev Urol; 2020 Jul; 17(7):407-421. PubMed ID: 32533118
[TBL] [Abstract][Full Text] [Related]
3. The genetics of kidney stone disease and nephrocalcinosis.
Singh P; Harris PC; Sas DJ; Lieske JC
Nat Rev Nephrol; 2022 Apr; 18(4):224-240. PubMed ID: 34907378
[TBL] [Abstract][Full Text] [Related]
4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
5. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
[TBL] [Abstract][Full Text] [Related]
6. Renal stone disease.
Sayer JA
Nephron Physiol; 2011; 118(1):p35-44. PubMed ID: 21071986
[TBL] [Abstract][Full Text] [Related]
7. The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25.
Guerra A; Ticinesi A; Allegri F; Nouvenne A; Pinelli S; Folesani G; Lauretani F; Maggio M; Borghi L; Meschi T
Urolithiasis; 2016 Nov; 44(6):521-528. PubMed ID: 27038481
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
9. Calcium stone disease: a multiform reality.
Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
[TBL] [Abstract][Full Text] [Related]
10. [Calcium kidney stones. Diagnostic and preventive prospects].
Arcidiacono T; Terranegra A; Biasion R; Soldati L; Vezzoli G
G Ital Nefrol; 2007; 24(6):535-46. PubMed ID: 18278757
[TBL] [Abstract][Full Text] [Related]
11. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
[TBL] [Abstract][Full Text] [Related]
12. Genetics and calcium nephrolithiasis.
Vezzoli G; Terranegra A; Arcidiacono T; Soldati L
Kidney Int; 2011 Sep; 80(6):587-93. PubMed ID: 20962745
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.
Wang X; Krambeck AE; Williams JC; Tang X; Rule AD; Zhao F; Bergstralh E; Haskic Z; Edeh S; Holmes DR; Herrera Hernandez LP; Lieske JC
Clin J Am Soc Nephrol; 2014 Oct; 9(10):1757-63. PubMed ID: 25092598
[TBL] [Abstract][Full Text] [Related]
14. The composition and quantitative analysis of urinary calculi in patients with renal calculi.
Jawalekar S; Surve VT; Bhutey AK
Nepal Med Coll J; 2010 Sep; 12(3):145-8. PubMed ID: 21446361
[TBL] [Abstract][Full Text] [Related]
15. A new model of nephrolithiasis involving tubular dysfunction/injury.
Kumar S; Sigmon D; Miller T; Carpenter B; Khan S; Malhotra R; Scheid C; Menon M
J Urol; 1991 Nov; 146(5):1384-9. PubMed ID: 1942307
[TBL] [Abstract][Full Text] [Related]
16. Animal models of kidney stone formation: an analysis.
Khan SR
World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
18. Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones.
Chow K; Dixon J; Gilpin S; Kavanagh JP; Rao PN
Kidney Int; 2004 May; 65(5):1724-30. PubMed ID: 15086911
[TBL] [Abstract][Full Text] [Related]
19. [Future perspective on the prevention of nephrolithiasis].
Kohjimoto Y; Shinka T; Morimoto S; Nishihata M
Hinyokika Kiyo; 2004 Aug; 50(8):591-6. PubMed ID: 15471083
[TBL] [Abstract][Full Text] [Related]
20. Urinary stone risk factors in the descendants of patients with kidney stone disease.
Dissayabutra T; Kalpongkul N; Rattanaphan J; Boonla C; Srisa-Art M; Ungjaroenwathana W; Tosukhowong P
Pediatr Nephrol; 2018 Jul; 33(7):1173-1181. PubMed ID: 29594505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
